Adjuvant Radiotherapy for Thymic Neuroendocrine Tumors: A Case Report and Review of the Literature

Thymic carcinoid tumors are very rare. Between two and four percent of carcinoids originate from the thymus with an estimated incidence of 1.5 to 3 per 10,000,000 persons per year. Thymic carcinoids can be associated with the multiple endocrine neoplasia (MEN) type 1. The principal treatment is surg...

Descripción completa

Detalles Bibliográficos
Autores principales: Iskanderani, Omar, Roberge, David, Coulombe, Geneviève
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406174/
https://www.ncbi.nlm.nih.gov/pubmed/28451474
http://dx.doi.org/10.7759/cureus.1115
_version_ 1783231920516104192
author Iskanderani, Omar
Roberge, David
Coulombe, Geneviève
author_facet Iskanderani, Omar
Roberge, David
Coulombe, Geneviève
author_sort Iskanderani, Omar
collection PubMed
description Thymic carcinoid tumors are very rare. Between two and four percent of carcinoids originate from the thymus with an estimated incidence of 1.5 to 3 per 10,000,000 persons per year. Thymic carcinoids can be associated with the multiple endocrine neoplasia (MEN) type 1. The principal treatment is surgical resection. The potential roles of systemic and radiation treatments are a matter of debate. We describe the successful multidisciplinary treatment of a case of thymic carcinoid associated with MEN and review the literature pertaining to the use of adjuvant thoracic radiation.
format Online
Article
Text
id pubmed-5406174
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-54061742017-04-27 Adjuvant Radiotherapy for Thymic Neuroendocrine Tumors: A Case Report and Review of the Literature Iskanderani, Omar Roberge, David Coulombe, Geneviève Cureus Radiation Oncology Thymic carcinoid tumors are very rare. Between two and four percent of carcinoids originate from the thymus with an estimated incidence of 1.5 to 3 per 10,000,000 persons per year. Thymic carcinoids can be associated with the multiple endocrine neoplasia (MEN) type 1. The principal treatment is surgical resection. The potential roles of systemic and radiation treatments are a matter of debate. We describe the successful multidisciplinary treatment of a case of thymic carcinoid associated with MEN and review the literature pertaining to the use of adjuvant thoracic radiation. Cureus 2017-03-26 /pmc/articles/PMC5406174/ /pubmed/28451474 http://dx.doi.org/10.7759/cureus.1115 Text en Copyright © 2017, Iskanderani et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Radiation Oncology
Iskanderani, Omar
Roberge, David
Coulombe, Geneviève
Adjuvant Radiotherapy for Thymic Neuroendocrine Tumors: A Case Report and Review of the Literature
title Adjuvant Radiotherapy for Thymic Neuroendocrine Tumors: A Case Report and Review of the Literature
title_full Adjuvant Radiotherapy for Thymic Neuroendocrine Tumors: A Case Report and Review of the Literature
title_fullStr Adjuvant Radiotherapy for Thymic Neuroendocrine Tumors: A Case Report and Review of the Literature
title_full_unstemmed Adjuvant Radiotherapy for Thymic Neuroendocrine Tumors: A Case Report and Review of the Literature
title_short Adjuvant Radiotherapy for Thymic Neuroendocrine Tumors: A Case Report and Review of the Literature
title_sort adjuvant radiotherapy for thymic neuroendocrine tumors: a case report and review of the literature
topic Radiation Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406174/
https://www.ncbi.nlm.nih.gov/pubmed/28451474
http://dx.doi.org/10.7759/cureus.1115
work_keys_str_mv AT iskanderaniomar adjuvantradiotherapyforthymicneuroendocrinetumorsacasereportandreviewoftheliterature
AT robergedavid adjuvantradiotherapyforthymicneuroendocrinetumorsacasereportandreviewoftheliterature
AT coulombegenevieve adjuvantradiotherapyforthymicneuroendocrinetumorsacasereportandreviewoftheliterature

Ejemplares similares